1. Hertogs, K., Mellors, J. W., Schel, P., Van Cauwenberghe, A., Larder, B., Kemp, S., Miller, V., Stasewski, S., Conant, M., & Pauwels, R. (1998). Patterns of cross-resistance among protease inhibitors in 483 clinical HIV-1 isolates. Abstract presented at the 5th Conference on Retroviruses and Opportunistic Infections, Chicago.
2. Antiretroviral drug resistance testing in adult HIV-1 infection: Recommendations of an international AIDS society-USA panel;Hirsch;Journal of the American Medical Association,2000
3. Potential mechanism for sustained antiretroviral efficacy of AZT-3TC combination therapy;Larder;Science,1995
4. Sequencing antiretrovirals, continuing medical education;MacArthur;AIDS Reader,2000
5. Mayers, D. L., Neaton J. D., Perez, G., Baxter, J. D., MacArthur, R. D., Markowitz, N. P., Dehlinger, M. E., Howard, S. F., Thompson, M. A., & CPCRA 036 Study Team. (1998). Prior saquinavir therapy leads to a modest decrease in subsequent responses to drug regimens containing indinavir or ritonavir. Abstract presented at the 5th Conference on Retroviruses and Opportunistic Infections, Chicago.